Skip to main content
Publications
Girardi A, Limoncella G, Hyeraci G, Roberto G, Bartolini C, Paoletti O, Messina D, Villalobos F, Bissacco C, Van den Burg J, Houben E, Santaca k, Lentile V, Ingrasciotta Y, Trifiro G, Hoxhaj V, Duran C, Riera-Arnau J, Garcia P, Martin-Perez M, Huerta-Alvarez C, Llorente-Garcia A, Sanchez-Saez F, Rodriguez-Bernal C, Lassalle R, Jove J, Bernard M, Thurin N, Jordan S, Thayer D, Evans H, Coldea A, Manfrini M, Van Gelder M, Hayati S, Schink T, Tari M, Pajouheshnia R , Afonso A, Noan-Laine M, Molgaard-Nielsen D, Cunnington M, Dodd C, Sturkenboom M, Nordeng H, Gini R. Impact of data source diversity on the distribution of key variables in pregnancy cohorts based on the ConcePTION pregnancy algorithm leveraging a random forest imputation model . Presented at the 2024 ISPE Annual Meeting; August 28, 2024. Berlin, Germany.
Layton JB , Muthuri S, Lindaas A, Lloyd PC, Richey MM, Gruber JF, Clarke TC, Kowarski LS, McKillop M, Fisher S, Lyu H, Cheng A, Bui CL , Duenas PF, Chen Y, Forshee RA, Anderson SA, Beers JB, Burrell T, Chillarige Y, Anthony MS , Shoaibi A. Risk of neurologic or immune-mediated adverse events after COVID-19 diagnosis in the United States . Presented at the 2024 ISPE Annual Meeting; August 28, 2024. Berlin, Germany.
Peetluk LS, Djibo DA, Layton JB , Deng J, Deshazo J, Richey MM, Ogilvie RP, Parambi RJ, Miller M, Song J, Tarazi W, Weatherby LB, Bell EJ, Anthony MS , McMahill-Walraven CN, Yang GW, Seeger JD, Amend KL. Considerations for negative control outcome analyses in vaccine effectiveness studies: post-hoc analyses from an adult vaccine effectiveness study conducted within the FDA BEST initiative . Presented at the 2024 ISPE Annual Meeting; August 27, 2024. Berlin, Germany.
Broe A, Willis SK, Dareng E, Haviland M, van Gelder MMHJ, Nordeng HME, Wood ME, Sahin L, Margulis AV , Rivero-Ferrer E . Building global consensus on definitions for drug safety studies in pregnancy to improve harmonized evaluation of real-world data . Presented at the 2024 ISPE Annual Meeting; August 27, 2024. Berlin, Germany.
Layton JB , Richey M, Lindaas A, Muthuri S, Lloyd PC, Gruber JF, Bui C , McKillop M, Kowarski L, Lyu H, Cheng A, Wan Z, Clarke TC, Kawai AT , Beers J, Forshee RA, Anderson SA, Burrell T, Chillarige Y, Anthony MS , Shoaibi A. Events on day zero of follow-up: considerations for cohort studies of adverse events after COVID-19 diagnosis . Presented at the 2024 ISPE Annual Meeting; August 27, 2024. Berlin, Germany.
Rao S , Forns J , Danysh HE , Calingaert B , Dempsey C, Aquilina T, Pathak S, Anthony MS , Layton JB . Natural history and clinical outcomes in patients with Alzheimer's disease-related psychosis in the United States . Presented at the International Conference on Alzheimer's and Parkinson's Diseases (AD/PD) 2024; March 5, 2024. Lisbon, Portugal.
Thomsen RW, Andersen IT, Kristensen FP, Munch PV, Pladevall-Vila M , Johannes C , Saigi-Morgui N , Ziemiecki R , Layton J , Vizcaya D, Gay A, Farjat A, Liu F, Oberprieler N, Christiansen CF. Clinical profile and kidney function of SGLT2i and GLP-1RA new users with CKD and type 2 diabetes in Denmark: a nationwide population-based study part of the FOUNTAIN platform . Presented at the 59th Annual Meeting European Association for the Study of Diabetes (EASD) 2023; October 4, 2023. Hamburg, Germany.
Gilsenan AW , Sturkenboom MC, De Luise C, Cohet C, Anderson SA, Brown J, Foskett N, Perez-Gutthann S . COVID-19 vaccine safety monitoring: opportunities, challenges and lessons learned for pharmacoepidemiology . Presented at the 2022 ICPE Conference; August 27, 2022. Copenhagen, Denmark.
Lund JL, Garcia de Albeniz X , Maringe C, Gaber C, Wyss R, Salas M, Ghazarian A. Cloning, censoring, and weighting – oh my! Applications of target trial emulation for evaluating cancer interventions when study eligibility, intervention initiation, and start of follow-up are not aligned . Presented at the 2022 ICPE Conference; August 27, 2022. Copenhagen, Denmark.
Fuller CC, Kawai AT , Haynes K, Coughlin K, Reynolds JS, Hawrusik R, Horgan C, Calingaert B , Johannes CB , Bradley Layton J , Peterson A, Praet N, Willame C, Yost E, Brannan C, McMahill-Walraven CNN, Guzman M, Jamal-allial A, Nair V, Seals RM, Wang FT, Selvan M, Ma Q, Platt R, Gilsenan AW , Brown J. Capacity for identifying Janssen Ad26.COV2.S COVID-19 vaccination in four US health insurance and state Immunization Information System databases: preparation for a post authorization safety study . Presented at the 2022 ICPE Conference; August 2022. Copenhagen, Denmark.
Setoguchi S, Lai E, Gini R, Pajouheshnia R , Platt RW, Hall G, Kim J-H, Ilomaki J, Salinas CD. Methods to address heterogeneity in multi-database studies in pharmacoepidemiology: search for consensus and future directions . Presented at the ISPES 13th Asian Conference; October 15, 2021. Seoul, South Kroea.
Hoffman V, Hallas J, Linder M, Margulis AV , Suehs BT, Arana A , Enger C, Horter L, Odsbu I, Olesen M, Perez-Gutthann S , Xu Y, Kristiansen NS, Appenteng K, de Vogel S, Seeger JD. Cardiovascular risk in users of mirabegron relative to users of antimuscarinic treatments for overactive bladder: findings from a non-interventional, real-world data safety study . Presented at the Virtual ICPE 2021 Conference; August 24, 2021. Previously presented at the 2020 Virtual American Heart Association’s Scientific Sessions.